Michael Petusky
Stock Analyst at Barrington Research
(3.40)
# 1,093
Out of 4,412 analysts
91
Total ratings
47.96%
Success rate
2.57%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Outperform | $38 | $29.89 | +27.13% | 7 | Apr 24, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $41 | $30.01 | +36.62% | 10 | Apr 18, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $98 | $74.10 | +32.25% | 9 | Apr 16, 2024 | |
| HAE Haemonetics | Maintains: Outperform | $105 | $91.95 | +14.19% | 13 | Apr 12, 2024 | |
| OPK OPKO Health | Maintains: Outperform | $1.5 | $1.22 | +22.95% | 4 | Apr 1, 2024 | |
| VRME VerifyMe | Maintains: Outperform | $1.7 | $2.26 | -24.75% | 4 | Mar 22, 2024 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $29 → $37 | $25.89 | +42.91% | 7 | Mar 14, 2024 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $120 → $122 | $101.51 | +20.19% | 10 | Mar 1, 2024 | |
| HSIC Henry Schein | Maintains: Outperform | $82 → $90 | $69.28 | +29.91% | 6 | Feb 28, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $66 → $69 | $64.80 | +6.48% | 4 | Feb 28, 2024 | |
| MODV ModivCare | Downgrades: Market Perform | n/a | $23.47 | - | 7 | Feb 26, 2024 | |
| SRDX Surmodics | Maintains: Outperform | $69 → $71 | $25.69 | +176.37% | 4 | Nov 9, 2023 | |
| LFCR Lifecore Biomedical | Maintains: Outperform | $11 → $10 | $6.42 | +55.76% | 5 | Sep 1, 2023 | |
| ATIP ATI Physical Therapy | Downgrades: Market Perform | n/a | $4.17 | - | 1 | Jul 27, 2021 |
Option Care Health
Apr 24, 2024
Maintains: Outperform
Price Target: $38
Current: $29.89
Upside: +27.13%
DENTSPLY SIRONA
Apr 18, 2024
Maintains: Outperform
Price Target: $41
Current: $30.01
Upside: +36.62%
Merit Medical Systems
Apr 16, 2024
Maintains: Outperform
Price Target: $98
Current: $74.10
Upside: +32.25%
Haemonetics
Apr 12, 2024
Maintains: Outperform
Price Target: $105
Current: $91.95
Upside: +14.19%
OPKO Health
Apr 1, 2024
Maintains: Outperform
Price Target: $1.5
Current: $1.22
Upside: +22.95%
VerifyMe
Mar 22, 2024
Maintains: Outperform
Price Target: $1.7
Current: $2.26
Upside: -24.75%
Anika Therapeutics
Mar 14, 2024
Maintains: Outperform
Price Target: $29 → $37
Current: $25.89
Upside: +42.91%
U.S. Physical Therapy
Mar 1, 2024
Maintains: Outperform
Price Target: $120 → $122
Current: $101.51
Upside: +20.19%
Henry Schein
Feb 28, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $69.28
Upside: +29.91%
LeMaitre Vascular
Feb 28, 2024
Maintains: Outperform
Price Target: $66 → $69
Current: $64.80
Upside: +6.48%
ModivCare
Feb 26, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $23.47
Upside: -
Surmodics
Nov 9, 2023
Maintains: Outperform
Price Target: $69 → $71
Current: $25.69
Upside: +176.37%
Lifecore Biomedical
Sep 1, 2023
Maintains: Outperform
Price Target: $11 → $10
Current: $6.42
Upside: +55.76%
ATI Physical Therapy
Jul 27, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.17
Upside: -